# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 65


For regulation 88 (omission of regulation 79 (failure to provide information on marketing authorisations to EMA)) substitute—
“Amendment of regulation 79 (failure to provide information on marketing authorisations to EMA)
88. In regulation 79 (failure to provide information on marketing authorisations to EMA)—
(a) in paragraph (1), for the first reference to “a marketing authorisation” substitute “a UKMA(NI) or UKMA(UK)”;
(b) in paragraph (2), for the first reference to “a marketing authorisation” substitute “UKMA(NI) or UKMA(UK)”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/65 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-65
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.